Actively Recruiting
A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
Led by Climb Bio, Inc. · Updated on 2026-04-30
45
Participants Needed
45
Research Sites
109 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate the safety and tolerability of three dose regimens of budoprutug in subjects with PMN
CONDITIONS
Official Title
A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed diagnosis of primary membranous nephropathy with positive anti-PLA2R antibodies
- CD19+ B cell count of 40 cells/µL or higher
- Urine protein-to-creatinine ratio of 2.0 g/g or higher
- Estimated glomerular filtration rate (eGFR) of 35 mL/min/1.73 m² or higher
- Stable treatment with RAAS inhibitors
- Blood pressure below 150/90 mmHg at baseline
- Adequate blood, liver, and kidney function
- Willingness to use effective contraception (for both sexes)
- Other inclusion criteria may apply
You will not qualify if you...
- Secondary membranous nephropathy
- Rapidly progressive glomerulonephritis or other glomerulopathies
- Prior B cell-depleting therapy within the last 24 weeks
- Recent use of immunosuppressant drugs
- Active infections or high risk of infection
- History of cancer
- Pregnancy or breastfeeding
- Recent major surgery or hospitalization
- Other exclusion criteria may apply
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 45 locations
1
Climb Bio Investigative Site #110
Denver, Colorado, United States, 80220
Actively Recruiting
2
Climb Bio Investigative Site #105
Orlando, Florida, United States, 32086
Actively Recruiting
3
Climb Bio Investigative Site #108
Atlanta, Georgia, United States, 30342
Actively Recruiting
4
Climb Bio Investigative Site #106
Indianapolis, Indiana, United States, 46268
Actively Recruiting
5
Climb Bio Investigative Site #101
Clifton Park, New York, United States, 12065
Actively Recruiting
6
Climb Bio Investigative Site #102
Philadelphia, Pennsylvania, United States, 19104
Not Yet Recruiting
7
Climb Bio Investigative Site #103
El Paso, Texas, United States, 79932
Actively Recruiting
8
Climb Bio Investigative Site #104
Sherman, Texas, United States, 75092
Actively Recruiting
9
Climb Bio Investigative Site# 602
Buenos Aires, Argentina, B1629
Actively Recruiting
10
Climb Bio Investigative Site# 603
Buenos Aires, Argentina, B1888
Actively Recruiting
11
Climb Bio Investigative Site #601
CABA, Argentina, C1111
Actively Recruiting
12
Climb Bio Investigative Site #604
CABA, Argentina, C1425
Actively Recruiting
13
Climb Bio Investigative Site #605
Córdoba, Argentina, C1425
Not Yet Recruiting
14
Climb Bio Investigative Site #606
Santa Fe, Argentina, S3000
Actively Recruiting
15
Climb Bio Investigative Site #502
Belo Horizonte, Brazil, 30150-320
Actively Recruiting
16
Climb Bio Investigative Site #505
Minas Gerais, Brazil, 36010-570
Actively Recruiting
17
Climb Bio Investigative Site #506
Pernambuco, Brazil, 50670-901
Not Yet Recruiting
18
Climb Bio Investigative Site #501
Porto Alegre, Brazil, 90020-090
Actively Recruiting
19
Climb Bio Investigative Site #503
São Paulo, Brazil, 05403-000
Actively Recruiting
20
Climb Bio Investigative Site #504
São Paulo, Brazil, 05403-000
Actively Recruiting
21
Climb Bio Investigative Site #701
Temuco, Araucania, Chile, 4811230
Not Yet Recruiting
22
Climb Bio Investigative Site #703
Valdivia, Los Ríos Region, Chile, 5020000
Not Yet Recruiting
23
Climb Bio Investigative Site #702
Santiago, Santiago Metropolitan, Chile, 8320165
Not Yet Recruiting
24
Climb Bio Investigative Site #403
Beijing, Changping District, China, 102218
Not Yet Recruiting
25
Climb Bio Investigative Site #401
Beijing, Cheng District, China, 100034
Not Yet Recruiting
26
Climb Bio Investigative Site #408
Shenzhen, Guangdong, China, 518036
Not Yet Recruiting
27
Climb Bio Investigative Site #402
Wuxi, Jiangsu, China, 214023
Not Yet Recruiting
28
Climb Bio Investigative Site #407
Xi'an, Shaanxi, China, 710061
Not Yet Recruiting
29
Climb Bio Investigative Site #405
Jinan, Shandong, China, 250014
Not Yet Recruiting
30
Climb Bio Investigative Site #409
Yantai, Shandong, China, 264000
Not Yet Recruiting
31
Climb Bio Investigative Site #404
Yibin, Sichuan, China, 644000
Not Yet Recruiting
32
Climb Bio Investigative Site #406
Beijing, Xicheng District, China, 100044
Not Yet Recruiting
33
Climb Bio Investigative Site #903
Tbilisi, Georgia, 0112
Actively Recruiting
34
Climb Bio Investigative Site #902
Tbilisi, Georgia, 0114
Actively Recruiting
35
Climb Bio Investigative Site #901
Tbilisi, Georgia, 0144
Actively Recruiting
36
Climb Bio Investigative Site #204
Taichung, Taiwan, 404
Actively Recruiting
37
Climb Bio Investigative Site# 202
Taipei, Taiwan, 100
Not Yet Recruiting
38
Climb Bio Investigative Site# 201
Taipei, Taiwan, 110
Actively Recruiting
39
Climb Bio Investigative Site #205
Taipei, Taiwan, 112
Actively Recruiting
40
Climb Bio Investigative Site# 203
Taipei, Taiwan, 235
Not Yet Recruiting
41
Climb Bio Investigative Site #803
Ivano-Frankivsk, Ukraine, 76008
Actively Recruiting
42
Climb Bio Investigative Site# 801
Kyiv, Ukraine, 02125
Actively Recruiting
43
Climb Bio Investigative Site #805
Kyiv, Ukraine, 03151
Actively Recruiting
44
Climb Bio Investigative Site #804
Rivne, Ukraine, 33027
Actively Recruiting
45
Climb Bio Investigative Site #802
Ternopil, Ukraine, 46002
Actively Recruiting
Research Team
C
Climb Bio Study Director
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here